Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia – prospective long-term results from a randomized-controlled trial

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus et al. · New England Journal of Medicine · 2002 · 2K citations · Full text

Life Sciences, Hematology, Oncology +14

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis

E. Jenny Heathcote, Mitchell L. Shiffman, W. Graham E. Cooksley et al. · New England Journal of Medicine · 2000 · 886 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia

François Guilhot, Claude Chastang, Mauricette Michallet et al. · New England Journal of Medicine · 1997 · 553 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

Rüdiger Hehlmann, H. Heimpel, Joerg Hasford et al. · Blood · 1994 · 458 citations · Full text

Medicine, Hematology, Oncology +10

Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy

Hagop M. Kantarjian · Annals of Internal Medicine · 1995 · 430 citations

Medicine, Hematology, Oncology +17